Spots Global Cancer Trial Database for Long-term Safety of Dasatinib in Patients With Chronic Myelogenous Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Long-term Safety of Dasatinib in Patients With Chronic Myelogenous Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Official Title: Dasatinib in Chronic Myelogenous Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemic Subjects Who Are Experiencing Clinical Benefit on Current START or CA180-039 Protocols: Long Term Safety and Efficacy Analysis
Study ID: NCT00982488
Conditions
Study Description
Brief Summary: This study assesses the long-term safety and tolerability of dasatinib administered to patients with chronic myelogenous leukemia or Philadelphia chromosome positive acute lymphoblastic leukemia and experienced clinical benefit from treatment with dasatinib or imatinib in previous protocols.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Pacific Cancer Medical Center Inc, Anaheim, California, United States
Loma Linda University Cancer Center, Loma Linda, California, United States
Ucla Department Of Medicine, Los Angeles, California, United States
Stanford University School Of Medicine, Stanford, California, United States
Kaiser Permanente Medical Center, Vallejo, California, United States
H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States
University Of Chicago, Chicago, Illinois, United States
Central Indiana Cancer Centers, Indianapolis, Indiana, United States
University Of Kansas Medical Center, Westwood, Kansas, United States
Dana Faber Cancer Institute, Boston, Massachusetts, United States
University Of Michigan Medical Center, Ann Arbor, Michigan, United States
Wayne State University, Detroit, Michigan, United States
John Theurer Cancer Center, Hackensack, New Jersey, United States
Oregon Health & Sci Univ, Portland, Oregon, United States
Western Pennsylvania Hospital, Pittsburgh, Pennsylvania, United States
Ut Southwestern Medical Center At Dallas, Dallas, Texas, United States
The University Of Texas Md Anderson Cancer Center, Houston, Texas, United States
Local Institution, Capital Federal, Buenos Aires, Argentina
Local Institution, Buenos Aires, , Argentina
Local Institution, Buenos Aires, , Argentina
Local Institution, Adelaide, South Australia, Australia
Local Institution, Mont-godinne, , Belgium
Local Institution, Curitiba, Parana, Brazil
Local Institution, Campinas, San Paulo, Brazil
Local Institution, Rio de Janeiro, , Brazil
Local Institution, Sao Paulo, , Brazil
Local Institution, Sao Paulo, , Brazil
Local Institution, Toronto, Ontario, Canada
Local Institution, Montreal, Quebec, Canada
Local Institution, Helsinki, , Finland
Local Institution, Lille, , France
Local Institution, Lyon Cedex 03, , France
Local Institution, Nantes, , France
Local Institution, Paris, , France
Local Institution, Pessac, , France
Local Institution, Poitiers Cedex, , France
Local Institution, Strasbourg, , France
Local Institution, Hamburg, , Germany
Local Institution, Leipzig, , Germany
Local Institution, Mannheim, , Germany
Local Institution, Budapest, , Hungary
Local Institution, Dublin 8, Dublin, Ireland
Local Institution, Ramat-gan, , Israel
Local Institution, Bologna, , Italy
Local Institution, Napoli, , Italy
Local Institution, Orbassano (to), , Italy
Local Institution, Roma, , Italy
Local Institution, Jeollanam-do, , Korea, Republic of
Local Institution, Seoul, , Korea, Republic of
Local Institution, Trondheim, , Norway
Local Institution, Lima, , Peru
Local Institution, Lima, , Peru
Local Institution, Katowice, , Poland
Local Institution, Krakow, , Poland
Local Institution, Lodz, , Poland
Local Institution, Lublin, , Poland
Local Institution, Warsaw, , Poland
Local Institution, Moscow, , Russian Federation
Local Institution, St.petersburg, , Russian Federation
Local Institution, Groenkloof, Gauteng, South Africa
Local Institution, Parktown, Gauteng, South Africa
Local Institution, Barcelona, , Spain
Local Institution, Gothenburg, , Sweden
Local Institution, Lund, , Sweden
Local Institution, Stockholm, , Sweden
Local Institution, Umea, , Sweden
Local Institution, Uppsala, , Sweden
Local Institution, Basel, , Switzerland
Local Institution, Bangkok, , Thailand
Local Institution, London, Greater London, United Kingdom
Local Institution, Glasgow, Scotland, United Kingdom
Local Institution, Newcastle, Tyne And Wear, United Kingdom
Contact Details
Name: Bristol-Myers Squibb
Affiliation: Bristol-Myers Squibb
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
